Taysha Gene Therapies, Inc.
TSHA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$89,298 | -$111,566 | -$166,014 | -$174,523 |
| Dep. & Amort. | $1,245 | $1,371 | $1,172 | $492 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $13,103 | $7,905 | $18,043 | $18,184 |
| Change in WC | -$12,467 | -$18,012 | $18,518 | $28,667 |
| Other Non-Cash | $6,192 | $47,284 | $39,891 | $10,138 |
| Operating Cash Flow | -$81,225 | -$73,018 | -$88,390 | -$117,042 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$374 | -$3,869 | -$24,869 | -$21,554 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $11 | -$3,483 | -$61 | $0 |
| Investing Cash Flow | -$363 | -$7,352 | -$24,930 | -$21,554 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$3,450 | $0 | $39,957 |
| Stock Issued | $76,780 | $140,790 | $53,244 | -$360 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$96 | -$947 | -$1,147 | -$514 |
| Financing Cash Flow | $76,684 | $136,393 | $52,097 | $39,083 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$4,904 | $56,023 | -$61,223 | -$99,513 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $146,540 | $90,517 | $151,740 | $251,253 |
| End Cash | $141,636 | $146,540 | $90,517 | $151,740 |
| Free Cash Flow | -$81,599 | -$80,387 | -$113,259 | -$138,596 |